Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lithium Ion SCHEMBL6829441 | 1.00 | — | — | |
| Lithium Ion SCHEMBL11053322 | 0.95 | — | — | |
| Lithium Ion SCHEMBL30576673 | 0.95 | — | — | |
| Lithium Ion SCHEMBL1961 | 0.95 | — | — | |
| Potassium Ion SCHEMBL4999362 | 0.90 | — | — | |
| Lithium Ion SCHEMBL8602755 | 0.90 | — | — | |
| Lithium Ion SCHEMBL6354843 | 0.90 | — | — | |
| Iodomethane SCHEMBL7699034 | 0.86 | ALDH1A1 (0.31) | — | |
| SCHEMBL3176524 | 0.84 | — | — | |
| Potassium Ion SCHEMBL17568 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080221114-A1 | 2-(Cyclic Aminocarbonyl) Indoline Derivative and Medicinal Composition Containing the Same | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2008-09-11 | — | — | US | disclosed |
| EP-1840126-A1 | 2-(CYCLIC AMINOCARBONYL)INDOLINE DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THE SAME | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2007-10-03 | — | — | EP | disclosed |